SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Douglas G. Welnetz who wrote (2718)1/15/1998 4:03:00 PM
From: Afaq Sarwar  Read Replies (2) of 3906
 
Douglas G. Welnetz,

My first impression of the news is the same yours.

Compared to the off-shore financing that is in place at present (and will be retired now)this is significantly better. The present financing over time, most likely, would have created more dilution. This, my expectation is that would also tend to stabilize the share price to some extent. I am sure Tom Waite would hate to see others paying less than he is paying for his shares.

So under the circumstances they, most likely, could not have gotten any outside financing at much better terms. And these guys running the company sure would like to see their investment go up in value. Most importantly, unlike the off-shore investors, these guys will have to file with SEC befor they can sell.

It will be interesting to see where the price will eventually stabalize.

Afaq Sarwar
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News